Valneva News

Buy Rating on Valneva Supported by Promising Vaccine Developments and Solid Revenue Projections

TipRanksMar 26 09:25 ET

Valneva Analyst Ratings

BenzingaMar 22 13:57 ET

Valneva Analyst Ratings

BenzingaMar 21 06:40 ET

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $26 Price Target

BenzingaMar 21 06:42 ET

Buy Rating Affirmed for Valneva: Strong Core Growth and Strategic Financial Health

TipRanksMar 21 06:16 ET

Valneva Analyst Ratings

BenzingaFeb 29 15:02 ET

Buy Rating Affirmed for Valneva on Strong Vaccine Market Prospects and Positive Regulatory Developments

TipRanksFeb 29 10:15 ET

Valneva Analyst Ratings

BenzingaFeb 15 12:42 ET

Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Aurinia Pharmaceuticals (AUPH)

TipRanksFeb 15 12:20 ET

Valneva's Promising Financial Future Bolstered by Vaccine Developments and Strategic Sales: A Buy Rating Analysis

TipRanksFeb 5 11:35 ET

Buy Rating for Valneva as Ixchiq Vaccine Shows Market Promise and Progress in Pediatric Trials

TipRanksJan 10 09:05 ET

Positive Outlook for Valneva: A Buy Rating With a $26 Price Target

TipRanksJan 5 10:25 ET

Valneva Analyst Ratings

BenzingaDec 4, 2023 12:40 ET

Buy Rating Justified by Valneva's Promising Vaccine Prospects and Strong Market Potential

TipRanksDec 4, 2023 10:25 ET

Analysts Offer Insights on Healthcare Companies: Valneva (VALN) and Roivant Sciences (ROIV)

TipRanksNov 27, 2023 09:10 ET

Valneva Analyst Ratings

BenzingaNov 10, 2023 08:04 ET

Needham Reiterates Buy on Valneva, Maintains $22 Price Target

BenzingaSep 27, 2023 07:01 ET

Valneva Analyst Ratings

BenzingaSep 27, 2023 07:01 ET

Buy Rating for Valneva: Future Prospects and Financial Analysis

TipRanksSep 25, 2023 09:25 ET

Valneva Analyst Ratings

BenzingaSep 7, 2023 09:50 ET